已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Serum uric acid lowering and effects of sodium‐glucose cotransporter‐2 inhibitors on gout: A meta‐analysis and meta‐regression of randomized controlled trials

医学 痛风 内科学 危险系数 达帕格列嗪 荟萃分析 恩帕吉菲 安慰剂 随机对照试验 卡格列净 尿酸 置信区间 相对风险 2型糖尿病 糖尿病 内分泌学 替代医学 病理
作者
Mainak Banerjee,Rimesh Pal,Indira Maisnam,Subhankar Chowdhury,Satinath Mukhopadhyay
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:25 (9): 2697-2703 被引量:22
标识
DOI:10.1111/dom.15157
摘要

Abstract Aims To pool the effects of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors on gout and to investigate the association of these effects with baseline serum uric acid (SUA), SUA lowering, and underlying conditions, such as type 2 diabetes mellitus (T2DM)/heart failure (HF). Methods PubMed, Embase, Web of Science, Cochrane Library and clinical trial registry websites were searched for randomized controlled trials (RCTs) or post hoc analyses (≥1‐year duration; PROSPERO:CRD42023418525). The primary outcome was a composite of gouty arthritis/gout flares and commencement of anti‐gout drugs (SUA‐lowering drugs/colchicine). Hazard ratios (HRs) with 95% confidence interval (CI) were pooled using a generic inverse‐variance method with a random‐effects model. Mixed‐effects model univariate meta‐regression analysis was performed. Results Five RCTs involving 29 776 patients (T2DM, n = 23 780) and 1052 gout‐related events were identified. Compared to placebo, SGLT2 inhibitor use was significantly associated with reduced risk of composite gout outcomes (HR 0.55, 95% CI 0.45‐0.67; I 2 = 61%, P < 0.001). Treatment benefits did not differ between trials being conducted exclusively in baseline HF versus those conducted in patients with T2DM ( P ‐interaction = 0.37), but were greater with dapagliflozin 10 mg and canagliflozin 100/300 mg ( P < 0.01 for subgroup differences). Sensitivity analysis excluding trials that evaluated the effects of empagliflozin 10/25 mg (HR 0.68, 95% CI 0.57‐0.81; I 2 = 0%) accentuated the benefits of SGLT2 inhibitors with no between‐trial heterogeneity (HR 0.46, 95% CI 0.39‐0.55; I 2 = 0%). Univariate meta‐regression found no impact of baseline SUA, SUA lowering on follow‐up, diuretic use, or other variables on their anti‐gout effects. Conclusion We found that SGLT2 inhibitors significantly reduced the risk of gout in individuals with T2DM/HF. Lack of an association with SUA‐lowering effects suggests that metabolic and anti‐inflammatory effects of SGLT2 inhibitors may predominantly mediate their anti‐gout benefits.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lyon完成签到,获得积分10
1秒前
aa完成签到,获得积分10
3秒前
6秒前
饿哭了塞完成签到 ,获得积分10
8秒前
漂亮白枫发布了新的文献求助10
12秒前
14秒前
共享精神应助niu采纳,获得10
14秒前
Li完成签到,获得积分10
15秒前
研友_VZG7GZ应助拼搏的松鼠采纳,获得10
17秒前
轻松元绿完成签到 ,获得积分10
20秒前
执着的夜蓉完成签到,获得积分10
21秒前
21秒前
SciGPT应助1234567采纳,获得10
21秒前
田様应助漂亮白枫采纳,获得10
22秒前
22秒前
成就的笑南完成签到 ,获得积分10
24秒前
耶耶完成签到 ,获得积分10
24秒前
kw98完成签到 ,获得积分10
25秒前
哭泣灯泡完成签到,获得积分10
26秒前
普萘洛尔完成签到,获得积分10
26秒前
niu发布了新的文献求助10
26秒前
chem-w完成签到,获得积分20
27秒前
烊驼完成签到,获得积分10
28秒前
爆米花应助科研通管家采纳,获得10
28秒前
Lily应助科研通管家采纳,获得10
28秒前
共享精神应助科研通管家采纳,获得10
28秒前
28秒前
CipherSage应助科研通管家采纳,获得10
29秒前
29秒前
丘比特应助科研通管家采纳,获得10
29秒前
Akim应助科研通管家采纳,获得10
29秒前
传奇3应助科研通管家采纳,获得10
29秒前
Lily应助科研通管家采纳,获得10
29秒前
29秒前
打打应助科研通管家采纳,获得10
29秒前
Hayat应助科研通管家采纳,获得10
29秒前
29秒前
Ava应助科研通管家采纳,获得10
29秒前
29秒前
linmu完成签到 ,获得积分10
30秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976583
求助须知:如何正确求助?哪些是违规求助? 3520659
关于积分的说明 11204399
捐赠科研通 3257298
什么是DOI,文献DOI怎么找? 1798683
邀请新用户注册赠送积分活动 877842
科研通“疑难数据库(出版商)”最低求助积分说明 806595